Advancing science and implementing novel, cutting edge Technologies

StemBANCC aims to provide well characterised patient derived induced pluripotent stem cell lines and associated biomaterials in an accessible and sustainable bio-bank. StemBANCC also aims to demonstrate proof of concept for the utility of induced pluripotent stem cells in drug discovery for hard-to-treat disorders.

News & Events

ISSCR - Translational Opportunities in Stem Cell Research, 27 Feb - 1 March 2017

StemBANCC co-organised this international symposium where you could explore cutting-edge technology and the latest opportunities in stem cell research.

Click here to view the StemBANCC presentations at the ISSCR 2017.

CONCEPT: StemBANCC is a large-scale, 5 year academic-industry partnership in the area of stem cell research. It brings a consortium of 35 partners together who share their experience and collaborate in 12 work packages. It is a collaborative project between pharmaceutical companies, research institutions and small and medium enterprises (SMEs) to exploit the rich expertise across sectors and enhance knowledge transfer between academia and industry for patient benefit.

MAIN OBJECTIVE: The main aim of the StemBANCC project is to generate and characterise high quality human induced pluripotent stem (iPS) cell lines to study a range of chronic diseases (e.g. diabetes and dementia) and test for drug efficacy and safety.

Direct Links



INERIS (Institut National de l'Environnement Industriel et des Risques)
F-60550 Verneuil en Halatte


Project leader

Frederic Yves Bois
Phone +33 3 4455 6596


Project staff

Lydia Boutigny
Phone +33 3 4461 8120

Institute presentation

INERIS is a large public research institute whose mission is to provide scientific and technical assistance to the French Ministry for the Environment. With a staff of 600 persons, INERIS has extensive facilities and competence in toxicology in vitro, in vivo, and in silico. INERIS has experience in participating and managing large international research projects, including for the European Commission.

Within INERIS, the DRC/VIVA/METO (Models for Ecotoxicology and Toxicology) Unit, which includes 7 staff researchers, focuses its research activities on biomathematics, biostatistics and bioinformatics with applications to systems biology, quantitative in vitro to in vivo extrapolation, risk assessment, predictive toxicology and endocrine perturbation.

Coming soon after migration

Coming soon after migration...